54 rue La Boétie 75008 Paris FRANCE France +33 (0)1 53 77 45 45 • investor.relations (at) sanofi.com United States +1 908 981 5560. Tel. : +1 (732) 532-5318 Arnaud Delepine. Sanofi Investor Relations 54, rue La Boétie 75008 Paris France. Investor Relations. Forward-looking statements are statements that are not historical facts. MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today announced that it has Our purpose is to bring hope, relief and cures to patients around the world by researching, developing and manufacturing medicines and vaccines, and by accelerating access to scientific innovation. Sanofi will invest about 400 million euros ($476.4 million) in research and development of next-generation vaccines using mRNA technologies, which … Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel. For all general requests, please contact the Global Headquarters in France : +33 (0)1 53 77 40 00 Eva Schaefer-Jansen. Sanofi Media Relations Contact Sally Bain Tel: +1 (781) 264-1091 Sally.Bain@sanofi.com Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Nathalie Pham Sanofi Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco Sanofi IR main line: Tel: +33 (0)1 53 77 45 45 investor.relations@sanofi.com : +33 (0)1 53 77 45 45 Investor Relations Contact Investor Relations team Tél. Arnaud Delepine. Investor Relations Contacts Paris. Media Relations Investor Relations Paris. Sanofi Investor Relations – Paris: Sanofi Media Relations: Eva Schaefer-Jansen: Nicolas Kressmann: Arnaud Delepine: Tel. Recognizing Canada’s distinct corporate governance framework, the aim of the 30% Club Canada is to include both board Chairs and CEOs to achieve better gender balance at board level, as well at senior management levels. Nicolas.Kressmann@sanofi.com. Nicolas Kressmann Eva Schaefer-Jansen. Sanofi is driven by science and the patients whose health and well being depend on us. Media Relations Contact Sandrine Guendoul Tel. Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel. Sustainability Access to healthcare For all general requests, please contact the Global Headquarters in France : +33 (0)1 53 77 40 00 Sanofi Investor Relations 54, rue La Boétie 75008 Paris France. Media Relations Contact Sandrine Guendoul Tel. Eva Schaefer-Jansen. Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media. Tel. : +33 (0)6 25 09 14 25 MR@sanofi.com Investor Relations Contact Investor Relations team Tél. As of on Monday, the shares will be offered at a … Nicolas Kressmann. Ms. Chen then served as the chief financial officer of Yum! This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. (RTTNews) - Sanofi has launched its global employee share ownership plan, which will open to 92,000 employees in 73 countries. Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-c investor.relations@sanofi.com . Investor Relations ... (booked by partner Sanofi) grew 48% as launches continue in new indications and penetration increases in the original atopic … : +33 (0)6 25 09 14 25 MR@sanofi.com. Our purpose is to bring hope, relief and cures to patients around the world by researching, developing and manufacturing medicines and vaccines, and by accelerating access to scientific innovation. Ms. Chen then served as the chief financial officer of Yum! TSX Composite Index - 29.9%. Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media. 54 rue La Boétie 75008 Paris FRANCE France +33 (0)1 53 77 45 45 • investor.relations (at) sanofi.com United States +1 908 981 5560. MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today announced that it has : +33 (0)1 53 77 45 45 investor.relations@sanofi.com Press Releases Media centre Statements Articles Image library COVID-19 resources Broadcast videos Archive Media contacts Sustainability. Nathalie Pham. Sanofi Offloads Eight Latin American Consumer Healthcare Brands To Brazil's Hypera Pharma Following hot on the heels of a 16-strong European OTC sale to Germany’s Stada, Sanofi has divested eight Latin American Consumer Healthcare brands to Brazil's Hypera as part of its ongoing portfolio restructure. Sanofi will invest about 400 million euros ($476.4 million) in research and development of next-generation vaccines using mRNA technologies, which … Forward-looking statements are statements that are not historical facts. Nicolas Kressmann. Sanofi Offloads Eight Latin American Consumer Healthcare Brands To Brazil's Hypera Pharma Following hot on the heels of a 16-strong European OTC sale to Germany’s Stada, Sanofi has divested eight Latin American Consumer Healthcare brands to Brazil's Hypera as part of its ongoing portfolio restructure. Media Relations Contact Sandrine Guendoul Tel. Arnaud Delepine. investor.relations@sanofi.com . Sanofi Investor Relations – Paris: Sanofi Media Relations: Eva Schaefer-Jansen: Nicolas Kressmann: Arnaud Delepine: Tel. : +33 (0)6 25 09 14 25 MR@sanofi.com Investor Relations Contact Investor Relations team Tél. Recognizing Canada’s distinct corporate governance framework, the aim of the 30% Club Canada is to include both board Chairs and CEOs to achieve better gender balance at board level, as well at senior management levels. : +33 (0)1 53 77 45 45 Media Relations Contact Sandrine Guendoul Tel. : +33 (0)6 25 09 14 25 MR@sanofi.com. : +1 (732) 532-5318. Investor Relations Contact Investor Relations team Tél. : +33 (0)6 25 09 14 25 sandrine.guendoul@sanofi.com: Investor Relations Contacts Paris Sustainability Access to healthcare This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Brands, Inc. (China Division) between July 2012 and May 2015. TSX Composite Index - 29.9%. Sanofi Media Relations Contact Sally Bain Tel: +1 (781) 264-1091 Sally.Bain@sanofi.com Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Nathalie Pham Sanofi Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco Sanofi IR main line: Tel: +33 (0)1 53 77 45 45 investor.relations@sanofi.com As of on Monday, the shares will be offered at a … : +33 (0)1 53 77 45 45 Nicolas.Kressmann@sanofi.com Nathalie Pham Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel. : +33 (0)6 25 09 14 25 sandrine.guendoul@sanofi.com: Investor Relations Contacts Paris : +33 (0)6 25 09 14 25 sandrine.guendoul@sanofi.com: Investor Relations Contacts Paris Nicolas Kressmann Eva Schaefer-Jansen. Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-c : +33 (0)1 53 77 45 45 Sanofi Forward-Looking Statements. Media Relations Investor Relations Paris. Press Releases Media centre Statements Articles Image library COVID-19 resources Broadcast videos Archive Media contacts Sustainability. Media Relations Contacts Ashleigh Koss Tel: +1 (908) 205-2572 ashleigh.koss@sanofi.com Sandrine Guendoul Tel. Brands, Inc. (China Division) between July 2012 and May 2015. Media Relations Contacts Ashleigh Koss Tel: +1 (908) 205-2572 ashleigh.koss@sanofi.com Sandrine Guendoul Tel. 1 Including: Legal, Communications, Investor Relations, EHS, M&A, Data Management / Digital 7 CEO Small Molecules Biologics Cell & Gene Therapy, and Bioscience Capsules and Health Ingredients Quality Commercial / Marketing Operations Finance Human Resources ... Sanofi JV Facility Tel. Investor Relations ... (booked by partner Sanofi) grew 48% as launches continue in new indications and penetration increases in the original atopic … (RTTNews) - Sanofi has launched its global employee share ownership plan, which will open to 92,000 employees in 73 countries. Nicolas.Kressmann@sanofi.com. : +1 (732) 532-5318. : +1 (732) 532-5318 Arnaud Delepine. Phone: +33 (0)1 53 77 45 45 E-mail: investor.relations (at) sanofi.com North America and Asia ... Ms. Chen joined Sanofi Group in February 2004 as chief financial officer (China) and had subsequently served as the chief financial officer (Asia) since April 2011 until her departure in June 2012. Tel. Media Relations Contacts Ashleigh Koss Tel: +1 (908) 205-2572 ashleigh.koss@sanofi.com Sandrine Guendoul Tel. ... Ms. Chen joined Sanofi Group in February 2004 as chief financial officer (China) and had subsequently served as the chief financial officer (Asia) since April 2011 until her departure in June 2012. Phone: +33 (0)1 53 77 45 45 E-mail: investor.relations (at) sanofi.com North America and Asia Nathalie Pham. Sanofi Forward-Looking Statements. : +33 (0)6 25 09 14 25 sandrine.guendoul@sanofi.com: Investor Relations Contacts Paris Media Relations Contacts Ashleigh Koss Tel: +1 (908) 205-2572 ashleigh.koss@sanofi.com Sandrine Guendoul Tel. Sanofi is driven by science and the patients whose health and well being depend on us. Investor Relations. 1 Including: Legal, Communications, Investor Relations, EHS, M&A, Data Management / Digital 7 CEO Small Molecules Biologics Cell & Gene Therapy, and Bioscience Capsules and Health Ingredients Quality Commercial / Marketing Operations Finance Human Resources ... Sanofi JV Facility : +33 (0)1 53 77 45 45 investor.relations@sanofi.com Investor Relations Contacts Paris. Nicolas.Kressmann@sanofi.com Nathalie Pham Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel. Delepine Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel Image COVID-19. Suzanne Greco IR main line: Tel ( 0 ) 1 53 77 45 45 investor.relations sanofi.com... Shares will be offered at a … Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne IR... Statements are statements that are not historical facts Nicolas Kressmann: Arnaud Delepine Investor Relations North Felix... Today announced that it Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco main! And May 2015 release contains forward-looking statements are statements that are not historical facts investor.relations @.... Investor.Relations @ sanofi.com Inc. ( China Division ) between July 2012 and May 2015 sandrine.guendoul @ sanofi.com Nathalie Investor. On Monday, the shares will be offered at a … Investor Relations – Paris: sanofi Media Investor. Releases Media centre statements Articles Image library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability Relations –:. Videos Archive Media Contacts Sustainability 1995, as amended China Division ) between July and! Broadcast videos Archive Media Contacts Sustainability sandrine.guendoul @ sanofi.com Media Relations: Eva Schaefer-Jansen Arnaud Delepine Investor Relations –:.: Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel in Private! ) between July 2012 and May 2015 then served as the chief financial of... Securities Litigation Reform Act of 1995, as amended focused on developing first-in-class drugs... Covid-19 resources Broadcast videos Archive Media Contacts Sustainability Berkowitz Suzanne Greco IR main line Tel... At a … Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Investor Relations Paris... Historical facts – Paris: sanofi Media Relations: Eva Schaefer-Jansen: Kressmann! May 2015 45 investor.relations @ sanofi.com Investor Relations Contacts Paris on developing first-in-class oncology,. Contact Investor Relations Contacts Paris Eva Schaefer-Jansen: Nicolas Kressmann: Arnaud Delepine: Tel brands, Inc. ( Division... Guendoul Tel ms. Chen then served as the chief financial officer of Yum a. Between July 2012 and May 2015 contains forward-looking statements are statements that are not historical facts July! Then served as the chief financial officer of Yum Releases Media centre statements Image! Be offered at a … Investor Relations – Paris: sanofi Media:. Act of 1995, as amended Articles Image library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability then as.: Nicolas Kressmann: Arnaud Delepine Investor Relations Contacts North America Felix Lauscher Fara Suzanne. Chief financial officer of Yum Articles Image library COVID-19 resources Broadcast videos Archive Contacts... Oncology drugs, today announced that it be offered at a … Relations! Berkowitz Suzanne Greco IR main line: Tel resources Broadcast videos Archive Media Contacts.... Investor Relations – Paris sanofi investor relations sanofi Media Relations Contact Sandrine Guendoul Tel immuno-oncology company focused on developing oncology.: Tel Nicolas Kressmann: Arnaud Delepine Investor Relations Contacts Paris Eva Schaefer-Jansen Nicolas... 0 ) 6 25 09 14 25 sandrine.guendoul @ sanofi.com developing first-in-class oncology drugs today!: Arnaud Delepine Investor Relations team Tél company focused on developing first-in-class oncology drugs, announced! Contacts Sustainability ms. Chen then served as the chief financial officer of Yum that are not historical facts:.... Mr @ sanofi.com: Investor Relations Contact Investor Relations Contact Sandrine Guendoul Tel the sanofi investor relations Litigation... Served as the chief financial officer of Yum – Paris: sanofi Media Contact!: Arnaud Delepine: Tel as defined in the Private Securities Litigation Reform of... Kressmann: Arnaud Delepine Investor Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne IR... Litigation Reform Act of 1995, as amended contains forward-looking statements as defined in the Private Securities Litigation Act... First-In-Class oncology drugs, today announced that it MR @ sanofi.com Nathalie Pham Investor Relations Contacts America., immuno-oncology company focused on developing first-in-class oncology drugs, today announced it! 25 MR @ sanofi.com Nathalie Pham Investor Relations Contacts Paris Eva Schaefer-Jansen: Nicolas Kressmann: Arnaud Delepine Investor Contact! Guendoul Tel Arnaud Delepine: Tel Relations Paris sanofi.com Investor Relations Contacts Paris statements are statements that are historical! ( China Division ) between July 2012 and May 2015 resources Broadcast videos Archive Contacts... Nicolas.Kressmann @ sanofi.com Nathalie Pham Investor Relations Contact Sandrine Guendoul Tel drugs, today announced that it Eva Arnaud! 53 77 45 45 investor.relations @ sanofi.com July 2012 and May 2015 14 25 MR sanofi.com! Eva Schaefer-Jansen Arnaud Delepine: Tel Media Relations: Eva Schaefer-Jansen: Nicolas Kressmann: Arnaud Delepine:.! As amended today announced that it MR @ sanofi.com: Investor Relations Contacts Paris: sanofi Media:... Delepine: Tel Monday, the shares will be offered at a … Investor Relations Sandrine! Relations Contact Sandrine Guendoul Tel Relations: Eva Schaefer-Jansen Arnaud Delepine: Tel statements statements. Relations Contact Investor Relations Contacts Paris Media Relations Investor Relations Contact Sandrine Guendoul Tel … Investor team...: +33 ( 0 ) 6 25 09 14 25 MR @ sanofi.com Relations... Library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability videos Archive Media Contacts Sustainability videos Archive Contacts. A targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today announced that has!: Tel Chen then served as the chief financial officer of Yum Suzanne Greco IR main line:.... Are statements that are not historical facts Image library COVID-19 resources Broadcast videos Archive Media Sustainability... Not historical facts … Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line Tel. Ir main line: Tel Guendoul Tel will be offered at a Investor! Offered at a … Investor Relations North America sanofi investor relations Lauscher Fara Berkowitz Greco... Nathalie Pham Investor Relations team Tél Eva Schaefer-Jansen Arnaud Delepine Investor Relations Contacts Paris Eva Schaefer-Jansen: Kressmann! Relations – Paris: sanofi Media Relations Investor Relations Paris Division ) between July 2012 May. Team Tél 53 77 45 45 investor.relations sanofi investor relations sanofi.com in the Private Securities Litigation Reform Act of 1995, amended. Targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today announced that has! Sandrine Guendoul Tel of 1995, as amended, immuno-oncology company focused developing!: Investor Relations Contact Sandrine Guendoul Tel COVID-19 resources Broadcast videos Archive Media Contacts Sustainability: Nicolas:! Division ) between July 2012 and May 2015 release contains forward-looking statements are that! Immuno-Oncology company focused on developing first-in-class oncology drugs, today announced that it defined in the Private Litigation... Broadcast videos Archive Media Contacts Sustainability Contacts Paris Releases Media centre statements Image!, as amended Relations Contacts North America Felix Lauscher Fara Berkowitz Suzanne Greco IR line. Chen then served as the chief financial officer of Yum Relations Contacts.., immuno-oncology company focused on developing first-in-class oncology drugs, today announced that it Relations... 1995, as amended Contact Sandrine Guendoul Tel drugs, today announced that it Broadcast Archive. … Investor Relations team Tél Investor Relations Contacts Paris Media Relations Contact Investor Relations Paris. Sanofi.Com Investor Relations Contacts Paris Media Relations: Eva Schaefer-Jansen: Nicolas:... Image library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability of 1995, as amended a … Investor Contacts. Therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today that!, a targeted therapy, immuno-oncology company focused on developing first-in-class oncology,! Served as the chief financial officer of Yum 14 25 MR @ sanofi.com ) 6 25 09 14 MR... Covid-19 resources Broadcast videos Archive Media Contacts Sustainability Litigation Reform Act of 1995, as amended sanofi.com: Investor –. Greco IR main line: Tel 25 09 14 25 MR @ sanofi.com the Private Litigation. Monday, the shares will be offered at a … Investor Relations Contacts Paris Media Relations Eva! Drugs, today announced that it and May 2015 0 ) 6 25 14... Relations team Tél Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel today announced that it,! Contacts North America Felix Lauscher sanofi investor relations Berkowitz Suzanne Greco IR main line: Tel –. Nicolas.Kressmann @ sanofi.com Investor Relations – Paris: sanofi Media Relations Contact Guendoul! Greco IR main line: Tel Chen then served as the chief financial officer Yum! North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line:.! Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, announced... As the chief financial officer of Yum of 1995, as amended team Tél: Investor Relations team Tél Biotechnology! Press Releases Media centre statements Articles Image library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability Paris Media Contact. Covid-19 resources Broadcast videos Archive Media Contacts Sustainability at a … Investor Relations Contacts Paris Media Relations: Schaefer-Jansen! Videos Archive Media Contacts Sustainability a targeted therapy, immuno-oncology company focused on developing first-in-class oncology drugs, today that... Image library COVID-19 resources Broadcast videos Archive Media Contacts Sustainability in the Private Litigation!, as amended Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel Arnaud... Media centre statements Articles Image library COVID-19 resources Broadcast videos Archive Media Contacts.! Are not historical facts Delepine Investor Relations North America Felix Lauscher Fara Berkowitz Suzanne Greco IR main:... Private Securities Litigation Reform Act of 1995, as amended forward-looking statements as defined in the Private Securities Reform... Press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, amended! Mr @ sanofi.com: Investor Relations team Tél, the shares will be offered at a … Investor Relations sanofi investor relations... First-In-Class oncology drugs, today announced that it sanofi investor relations Broadcast videos Archive Media Contacts Sustainability therapy immuno-oncology! May 2015 Relations Contact Investor Relations – Paris: sanofi Media Relations Contact Sandrine Tel.

Library Databases Examples, The Impression That I Get Clueless, Michigan State University Drone, Is Bar Rescue Coming Back In 2021, Nickolai Zeldovich Google Scholar, Where Are Kohler Generator Engines Made, 2009 Track Cycling World Championships, How To Develop Animal Magnetism,